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Abstract
Modest information is available on how fasting affects clinical pathology variables in (Streptozocin) STZ induced 
diabetes mice and db/db mice. This study was carried out to evaluate the influence of fasting on clinical pathology 
variables in diabetic mouse models. Seven male STZ induced diabetic CD1 mice and db/db mice were fasted for 18 
hours and change in body weight (BW), hematologic and biochemical variables were evaluated. Fasting provoked 
significant variation in body weight, haematology and biochemical variables in diabetic animal models.
The results suggested that clinical pathology variables will vary after fasting. The decision to feed or fast before 
blood collection for analyzing the results should be made based on fasting in animal models for diabetic research.
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Introduction
Clinical pathology data of animal models used in diabetic 
research play an important part in non-clinical toxicity studies and 
safety evaluations of new drugs, food additives, and chemicals [1]. 
Many regulatory guidelines and the recommendations of American 
Association for Clinical Chemistry’s Division of Animal Clinical 
Chemistry (AACC-DACC) and the American Society for Veterinary 
Clinical Pathology (ASVCP) joint committee on clinical pathology 
testing of laboratory species requires overnight fasting of animals 
before blood sampling [2-4]. An important reason for fasting in 
laboratory animals before blood collection is to reduce variability 
of some clinical chemistry parameters between feeding and fasting 
conditions. However, intestinal physiologic functions and drug-
metabolizing enzymes may have some difference under feeding and 
fasting conditions [5-7]. Thus, the fasting in animals should be decided 
case by case rather than made uniform for every study. There are 
limited reports on the effects of fasting on certain clinical pathology 
variables; most of them focus on rats [8,9] but none defined in diabetic 
animal models. 
This study was undertaken to recognize variables after fasting 
and this study will provide a more complete picture of fasting effects 
on the on haematology and biochemical variables in diabetic animal 
models. In addition this result will help for designing toxicity or 
pharmacodynamics studies on diabetic animal models.
Materials and Methods
Experimental protocols were approved by the Institutional animal 
ethics Committee and experiments were conducted in accordance 
with the guidelines of Institutional Animal Use and Care of National 
Institute of Immunology New Delhi. Diabetic mice (db/db) mice on 
a C57BLKS/J background were obtained from the Jackson Laboratory 
(Bar Harbor, ME). The animals were maintained in individual 
ventilated cages at standard environmental conditions (temperature 
22–25°C, humidity 40–70%) with 14:10 dark/light photoperiods, Two 
diabetic models were used for this study, STZ induced CD1 mice and 
db/db mice. These strains are preferred as CD1 has greater induction 
of diabetes as compared to other strains and out bred CD-1 mice 
carry a spectrum of genetic susceptibilities for obesity and type 2 
diabetes. db/db on the other hand spontaneously develop hyperphagic, 
obese, on the other hand spontaneously develop hyperphagic, obese, 
hyperglycaemic, hyperinsulinaemic and insulin resistant within first 
month of age and develop hypoinsulinaemia, hyperglycaemia later 
with a peak between 3-4 months of age.
STZ induced diabetes in CD1 male mice
Diabetes was induced in CD1 mice by Streptozotocin (STZ), as 
described previously [10]. STZ (Sigma-Aldrich) was dissolved in 50 
mM sodium citrate buffer (pH 4.5) and a final concentration of 6 mg/
ml was made. The animals were injected intraperitoneally at a dose of 
45 mg/kg/day. Treatment was repeated for 5 consecutive days. Blood 
glucose level was measured, in non fasted animals on alternate days 
and mice were considered diabetic when blood glucose levels exceeded 
250 mg/dL. The animals achieved diabetic 7 to 9 days after the last STZ 
injection.
Fasting experiment: Seven male six to eight weeks db/db and STZ 
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induced CD1 mice were fasted for 18 h. The animals were housed in 
individual ventilated cages with free access to water. For pre fasting 
variables seven db/db and STZ induced diabetic male mice were used. 
Blood collection: At the end of the respective fasting period, 
blood was collected from each mouse by retro-orbital venous puncture 
under ketamine anaesthesia. 200 µl of blood sample were collected 
into micro centrifuge tubes containing 2% EDTA for hematologic 
analyses using MS 4e Vet Haematology Analyzer (Melet Schloesing) 
and analyzed as per manufactures instruction. 500 µl blood without 
EDTA were collected through cardiac puncture before euthanasia 
kept in refrigerator, allowed to clot for 60 min and centrifuged at 3000 
g×15 min at 4°C for biochemical analysis using Tulip 3000 Evolution 
biochemical Analyzer, India. The above procedures were followed in 
the non fasted control db/db, STZ induced CD1 mice. Following blood 
collection the animals were euthanized.
Statistics: All data’s were analyzed with GraphPad Prism version 6 
for Windows (GraphPad Software, San Diego, CA, USA). The data are 
expressed as the mean ± s.d. with median and range. Values for blood 
parameters obtained from pre fasted blood samples and post fasted 
were compared by using unpaired t tests. A p value of 0.05 was used as 
the threshold for statistical significance significant.
Results
The results of are summarized in table 1 and table 2. As shown 
in the table 1 there were significant differences in haematology after 
fasting in both db/db and STZ induced CD1 diabetic mice. There was 
significant increase in M, G, RBC, HCT, RDW, Hb and MPV in STZ 
induced CD1 mice and significant increase in G, PLA and Pct in db/
db mice. There was significant decrease in L, RBC, MCV and HCT on 
both models. 
As shown in the table 2 there was significant increase in T-BIL, 
Total P, Na, CREA in STZ induced CD1 mice and decrease in ALP, 
AST, ALT, CHO ,TGY, GLU Ca in STZ induced CD1 mice. In db/db 
mice there was significant increase in T- BIL, TGY, CHO, Uric acid and 
Total P and significant decrease in ALP and GLU.
Discussion
In diabetic research, the fasting is generally primed to study the 
various effects. As stated in the introductory section, it is evident that 
variables many variables are noticed after fasting and has large impact 
on the research. Given the almost mandatory use of the fasting we are 
surprised that an attempt has not previously been made to validate 
the various variables of this test in diabetic mice. The animals are in 
normal physiological state when given enough food and when food is 
withdrawn or fasted the physiological and pathological variation may 
take place. Fasting will affect the animal health, behaviour, absorption 
rate of test substances, carbohydrate and lipid metabolism [11]. 
Researchers using diabetic animals for research employ 16-24 hours 
fasting, but this fasting brings about important changes. These changes 
will affect internal cellular biochemistry and one should therefore 
expect differences in the effects of preparations on isolated cells, tissue 
or organs removed from animals that have, or have not, been fasted. 
Claassen [12] studies explain that many plasma values fall, including 
glucose, urea, lactate and amino acids, while glycerol and free fatty 
acids increase, after only 3 hours of fasting
After different durations of fasting, a significant loss of 1.8 to 
11.77% of BW was observed in rats and an average of 14% in pigs [13]. 
This similar effect on BW was observed in our study at18 hours of 
fasting in STZ induced CD1 mice but not in db/db mice. This changes 
might be due to lack of long-form leptin receptor. Most published 
articles stated that RBC, Hb, HCT increases after fasting laboratory 
Analyte Mean ±SD Median
(Range-Max – Min) Diabetic   CD1mice- Pre fasting
Diabetic  CD1 mice- Post 
fasting
Diabetic db/db mice Pre 
fasting
Diabetic db/db mice Post 
fasting
Body weight-BW 24.02 ± 3.10 25.75 (25.30-24.20) 22.60 ± 2.60* 22.5 (24.50-21.90) 36.68 ± 4.10 36.90 (37.50-33.10) 35.43 ± 2.40 35.10 (36.50-34.30)
Total WBC (× 103/μL) 6.71 ± 1.31 (6.81) (8.21-5.15)  4.65 ± 1.03* 4.57 (5.97-3.46) 8.47 ± 2.11 8.18 11.88-6.04 6.87 ± 2.17 6.48 10.89-4.69
Lymphocytes-L (%) 71.32 ± 3.07 71.95 (74.50-66.40) 41.15 ± 10.37* 40.90 (52.70-32.20) 79.98 ± 3.66 81.10 83.70-73.10 72.59 ± 3.51* 72.00 77.00-68.20
Monocytes -M(%) 7.53 ± 1.38 (8.05) (8.80-5.70) 14.08 ± 3.78* (14.05) (17.40-10.80) 6.43 ± 1.42 6.25 8.90-5.00 6.41 ± 1.60 5.95 9.00-4.70
Granulocytes-G (%)
 21.15 ± 2.30 21.20 (24.90-18.10)
44.78 ± 6.89* 45.00 (52.60-
32.60) 13.60 ± 2.41 13.15 18.00-11.20) 21.00 ± 2.58* 21.55 23.60-16.60
RBC (× 106/μL) 6.97 ± 0.49 7.02 (7.52-6.23) 7.78 ± 0.28* 7.90 (7.94-7.35) 9.18 ± 0.50 9.11 (9.93-8.35) 8.67 ± 0.40* 8.79 (9.26-7.91)
MCV (fL) 59.33 ± 0.56 59.20 (60.10-58.70) 59.63 ± 0.56 59.60 (60.20-59.10) 58.20 ± 0.68 58.40 (59.00-57.10)
57.34 ± 0.53* 57.30 (58.10-
56.40)
HCT (%) 41.33 ± 3.09 41.70 (45.00-36.50) 46.33 ± 1.91* 47.10 (47.60-43.50)
53.31 ± 3.33 52.65 (58.50-
47.60)
49.66 ± 2.71* 50.30 (53.80-
44.60)
MCH (pg) 17.43 ± 0.22 17.45 (17.70-17.10) 17.95 ± 0.24 17.85 (18.30-17.80) 17.50 ± 0.34 17.40 (18.10-17.10) 17.46 ± 0.38 17.40 (18.00-17.00)
 MCHC (g/dL) 29.43 ± 0.39 29.35 (30.10-29.10) 30.20 ± 0.6229.95 (31.10-29.80) 30.13 ± 0.36 30.10 (30.80-29.70) 30.50 ± 0.63 30.40 (31.50-29.80)
RDW (%) 9.52 ± 0.10 9.50 (9.70-9.40) 10.28 ± 0.25* 10.40 (10.40-9.90) 9.78 ± 0.56 9.60 (10.80-9.30) 9.66 ± 0.45 9.50 (10.40-8.90)
Hemoglobulin-Hb(%)
12.18 ± 0.76 12.25 (13.1-11) 14.00 ± 0.64* 14.15 (14.6-13.1) 16.10 ± 0.98 16.1 (17.4-14.3) 15.18 ± 0.90 15.2 (16.5-13.5)
Platelets -PLT(× 103/μL) 1,097.00 ± 28.74 (1052) (1489-842) 1,183.00 ± 218.42 (1134) (1488-976) 646.75 ± 63.49 625 (779-577) 909.75 ± 69.03* 904 (995-833)
  MPV (fL) 5.17 ± 0.23 5.15 (5.50-4.90) 5.53 ± 0.22* 5.50 (5.80-5.30) 5.48 ± 0.22 5.45 (5.80-5.10) 5.25 ± 0.20 5.30 (5.50-4.90)
Pct % 0.57 ± 0.12 0.55 (0.79-0.45) 0.65 ± 0.10 0.62 (0.80-0.57) 0.35 ± 0.02 0.35 (0.40-0.33) 0.47 ± 0.04* 0.48 (0.54-0.41)
 PDW 8.58 ± 0.37 8.50 (9.10-8.20) 9.00 ± 0.32 9.05 (9.30-8.60) 8.15 ± 0.49 8.15 (8.90-7.40) 8.51 ± 0.53 8.55 (9.10-7.60)
Table 1: Haematology values in Pre and post fasting variables of STZ induced CD1 mice and db/db Presented as mean ± standard deviation (n=7) with median and range 
*p<0.05. * p<0.05 compared with pre and post fasted mice using unpaired student t test
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animals [14,15]. But in this study there was significant increase in RBC 
and Hb but not HCT in STZ induced CD1 mice. The changes observed 
in WBC parameters were similar in both strains to those seen in SD 
rats and humans [14-16]. Studies on rats showed [8] PLT increased 
with percentage changes of 16.5% in male rats. In our study there was 
increase in PLT in db/db mice though not significantly in STZ induced 
CD1 mice. No noteworthy changes in RBC parameters were observed 
db/db mice but significant increase in RBC count in STZ induced CD1 
mice as reported in Wistar rats [17].
Serum biochemical variables like CHO and TGY had significant 
effect with increase in db/db mice on the other hand there were 
significant decrease in CHO and TGY in STZ induced CD1 mice. 
The liver enzymes AST and ALT showed significant decrease in 
STZ induced CD1 mice as reported previously on other species after 
overnight fasting [18] but there were no significant changes in db/
db mice. ALP and TOT-BIL were significantly increased in both the 
models. This change in ALP activity could be attributable to decreased 
production of the intestinal isoenzyme during fasting; as intestine is 
the major source of serum ALP [19]. There was significant increase 
in CREA level in db/db mice though not significant in STZ induced 
CD1 mice. Serum calcium obviously decreased after fasting, and it was 
similar to observations reported by Matsuzawa and Sakazume [11]. 
Calcium levels were decreased in STZ induced CD1 mice but not in 
db/db mice after fasting. This change in calcium in serum may be a 
consequence of a decrease in serum parathyroid hormone (PTH) after 
fasting, which might affect the reabsorption and secretion of Ca and P 
in kidney [20].
Clearly, the fasting has pronounced effects on clinical chemistry 
analytes and hematology in diabetic animal models. To conclude 
researchers using diabetic animal models for their research should 
consider effect of fasting for interpretation of their results. 
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